Lassa virus vaccine trial in Nigeria, Liberia and Sierra Leone
by Press Release from Outbreak News Today on (#5KV16)
By NewsDesk @infectiousdiseasenews The International AIDS Vaccine Initiative (IAVI) was awarded 22.8 million by the European & Developing Countries Clinical Trials Partnership and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct a Phase IIb clinical trial of IAVI's Lassa fever vaccine candidate among adults and children in Liberia, Nigeria, and Sierra Leone, according to a [...]
The post Lassa virus vaccine trial in Nigeria, Liberia and Sierra Leone appeared first on Outbreak News Today.